| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Department of Cell Biology, University of Cincinnati, Cincinnati, Ohio 45267-0521 [M. P. M., S. P. A., M. W. S., S. L. W., R. W. G., E. S. K.], and Divisions of Developmental Biology and Pediatric Informatics, The Childrens Hospital Research Foundation, Cincinnati, Ohio 45229-3039 [B. J. A.]
The retinoblastoma tumor suppressor, RB, is thought to inhibit cell cycle progression through transcriptional repression. E2F-regulated genes have been viewed as presumptive targets of RB-mediated repression. However, we found that specific E2F targets were not regulated in a consistent manner by the action of a RB allele that is refractory to cyclin-dependent kinase/cyclin-mediated phosphorylation (PSM-RB) when compared with E2F2 overproduction. Therefore, we used Affymetrix GeneChips as an unbiased approach to identify RB targets. We found that expression of PSM-RB significantly attenuates >200 targets, the majority of which are involved in cell cycle control (DNA replication or G2-M), DNA repair, or transcription/chromatin structure. The observed repression was due to the action of RB and not merely a manifestation of altered cell cycle distribution. Additionally, the majority of RB repression targets were confirmed through the blockade of endogenous RB phosphorylation via p16ink4a overexpression. Thus, these results have utility in assigning RB pathway activation in more complex systems of cell cycle inhibition (e.g., mitogen withdrawal, senescence, or DNA damage checkpoint). As expected, a significant fraction of RB-repressed genes have promoters that are bound/regulated by E2F family members. However, targets were identified that are distinct from genes known to be stimulated by overexpression of specific E2F proteins. Moreover, the relative action of RB versus E2F2 overexpression on specific genes demonstrates that a simple opposition model does not explain the relative contribution of RB to gene regulation. Thus, this study provides the first unbiased description of RB-repressed genes, thereby delineating new aspects of RB-mediated transcriptional control and novel targets involved in diverse cellular processes.
This article has been cited by other articles:
![]() |
K. R. Stengel, C. Thangavel, D. A. Solomon, S. P. Angus, Y. Zheng, and E. S. Knudsen Retinoblastoma/p107/p130 Pocket Proteins: PROTEIN DYNAMICS AND INTERACTIONS WITH TARGET GENE PROMOTERS J. Biol. Chem., July 17, 2009; 284(29): 19265 - 19271. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Zagorski, E. S. Knudsen, and M. F. Reed Retinoblastoma Deficiency Increases Chemosensitivity in Lung Cancer Cancer Res., September 1, 2007; 67(17): 8264 - 8273. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Teissier, Y. Ben Khalifa, M. Mori, P. Pautier, C. Desaintes, and F. Thierry A New E6/P63 Pathway, Together with a Strong E7/E2F Mitotic Pathway, Modulates the Transcriptome in Cervical Cancer Cells J. Virol., September 1, 2007; 81(17): 9368 - 9376. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yung, J. L. Walker, J. M. Roberts, and R. K. Assoian A Skp2 autoinduction loop and restriction point control J. Cell Biol., August 27, 2007; 178(5): 741 - 747. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. Srinivasan, C. N. Mayhew, S. Schwemberger, W. Zagorski, and E. S. Knudsen RB Loss Promotes Aberrant Ploidy by Deregulating Levels and Activity of DNA Replication Factors J. Biol. Chem., August 17, 2007; 282(33): 23867 - 23877. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sharma, C. E.S. Comstock, E. S. Knudsen, K. H. Cao, J. K. Hess-Wilson, L. M. Morey, J. Barrera, and K. E. Knudsen Retinoblastoma Tumor Suppressor Status Is a Critical Determinant of Therapeutic Response in Prostate Cancer Cells Cancer Res., July 1, 2007; 67(13): 6192 - 6203. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Villanueva, Y. Yung, J. L. Walker, and R. K. Assoian ERK Activity and G1 Phase Progression: Identifying Dispensable Versus Essential Activities and Primary Versus Secondary Targets Mol. Biol. Cell, April 1, 2007; 18(4): 1457 - 1463. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kothapalli, L. Zhao, E. A. Hawthorne, Y. Cheng, E. Lee, E. Pure, and R. K. Assoian Hyaluronan and CD44 antagonize mitogen-dependent cyclin D1 expression in mesenchymal cells J. Cell Biol., February 12, 2007; 176(4): 535 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cayrol, C. Lacroix, C. Mathe, V. Ecochard, M. Ceribelli, E. Loreau, V. Lazar, P. Dessen, R. Mantovani, L. Aguilar, et al. The THAP-zinc finger protein THAP1 regulates endothelial cell proliferation through modulation of pRB/E2F cell-cycle target genes Blood, January 15, 2007; 109(2): 584 - 594. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Reed, W. A. Zagorski, J. A. Howington, J. T. Zilfou, and E. S. Knudsen Inhibition of retinoblastoma tumor suppressor activity by RNA interference in lung cancer lines. Ann. Thorac. Surg., July 1, 2006; 82(1): 249 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Knudsen and K. E. Knudsen Retinoblastoma tumor suppressor: where cancer meets the cell cycle. Experimental Biology and Medicine, July 1, 2006; 231(7): 1271 - 1281. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-Q. An, H. M. Folarin, N. Compitello, J. Roth, S. L. Gerson, K. R. McCrae, F. D. Fakhari, D. P. Dittmer, and R. Renne Long-Term-Infected Telomerase-Immortalized Endothelial Cells: a Model for Kaposi's Sarcoma-Associated Herpesvirus Latency In Vitro and In Vivo. J. Virol., May 1, 2006; 80(10): 4833 - 4846. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chen, X. Huang, D. Halicka, S. Brodsky, A. Avram, J. Eskander, N. A. Bloomgarden, Z. Darzynkiewicz, and M. S. Goligorsky Contribution of p16INK4a and p21CIP1 pathways to induction of premature senescence of human endothelial cells: permissive role of p53 Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1575 - H1586. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Miller, F. Rangwala, J. Williams, P. Ackerman, S. Kong, A. G. Jegga, S. Kaiser, B. J. Aronow, S. Frahm, L. Kluwe, et al. Large-scale molecular comparison of human schwann cells to malignant peripheral nerve sheath tumor cell lines and tissues. Cancer Res., March 1, 2006; 66(5): 2584 - 2591. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Melcon, S. Kozlov, D. A. Cutler, T. Sullivan, L. Hernandez, P. Zhao, S. Mitchell, G. Nader, M. Bakay, J. N. Rottman, et al. Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regeneration Hum. Mol. Genet., February 15, 2006; 15(4): 637 - 651. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-L. Chen, F. Liu, S. Cai, X. Lin, A. Li, Y. Chen, B. Gu, E. Y.-H. P. Lee, and W.-H. Lee Inactivation of CtIP Leads to Early Embryonic Lethality Mediated by G1 Restraint and to Tumorigenesis by Haploid Insufficiency Mol. Cell. Biol., May 1, 2005; 25(9): 3535 - 3542. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. McCabe, J. N. Davis, and M. L. Day Regulation of DNA Methyltransferase 1 by the pRb/E2F1 Pathway Cancer Res., May 1, 2005; 65(9): 3624 - 3632. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Jackson, M. K. Agarwal, J. Yang, P. Bruss, T. Uchiumi, M. L. Agarwal, G. R. Stark, and W. R. Taylor, p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2 J. Cell Sci., May 1, 2005; 118(9): 1821 - 1832. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Bosco and E. S. Knudsen Differential role of RB in response to UV and IR damage Nucleic Acids Res., March 14, 2005; 33(5): 1581 - 1592. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-Q. An, N. Compitello, E. Horwitz, M. Sramkoski, E. S. Knudsen, and R. Renne The Latency-associated Nuclear Antigen of Kaposi's Sarcoma-associated Herpesvirus Modulates Cellular Gene Expression and Protects Lymphoid Cells from p16 INK4A-induced Cell Cycle Arrest J. Biol. Chem., February 4, 2005; 280(5): 3862 - 3874. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Fry, P. J. Harvey, P. R. Keller, W. L. Elliott, M. Meade, E. Trachet, M. Albassam, X. Zheng, W. R. Leopold, N. K. Pryer, et al. Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts Mol. Cancer Ther., November 1, 2004; 3(11): 1427 - 1438. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. A. Koroleva, M. Tomlinson, P. Parinyapong, L. Sakvarelidze, D. Leader, P. Shaw, and J. H. Doonan CycD1, a Putative G1 Cyclin from Antirrhinum majus, Accelerates the Cell Cycle in Cultured Tobacco BY-2 Cells by Enhancing Both G1/S Entry and Progression through S and G2 Phases PLANT CELL, September 1, 2004; 16(9): 2364 - 2379. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Markey, H. Siddiqui, and E. S. Knudsen Geminin Is Targeted for Repression by the Retinoblastoma Tumor Suppressor Pathway through Intragenic E2F Sites J. Biol. Chem., July 9, 2004; 279(28): 29255 - 29262. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Gunawardena, H. Siddiqui, D. A. Solomon, C. N. Mayhew, J. Held, S. P. Angus, and E. S. Knudsen Hierarchical Requirement of SWI/SNF in Retinoblastoma Tumor Suppressor-mediated Repression of Plk1 J. Biol. Chem., July 9, 2004; 279(28): 29278 - 29285. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Angus, C. N. Mayhew, D. A. Solomon, W. A. Braden, M. P. Markey, Y. Okuno, M. C. Cardoso, D. M. Gilbert, and E. S. Knudsen RB Reversibly Inhibits DNA Replication via Two Temporally Distinct Mechanisms Mol. Cell. Biol., June 15, 2004; 24(12): 5404 - 5420. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Thierry, M. A. Benotmane, C. Demeret, M. Mori, S. Teissier, and C. Desaintes A Genomic Approach Reveals a Novel Mitotic Pathway in Papillomavirus Carcinogenesis Cancer Res., February 1, 2004; 64(3): 895 - 903. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Bosco, C. N. Mayhew, R. F. Hennigan, J. Sage, T. Jacks, and E. S. Knudsen RB signaling prevents replication-dependent DNA double-strand breaks following genotoxic insult Nucleic Acids Res., January 2, 2004; 32(1): 25 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Vernell, K. Helin, and H. Muller Identification of Target Genes of the p16INK4A-pRB-E2F Pathway J. Biol. Chem., November 14, 2003; 278(46): 46124 - 46137. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Siddiqui, D. A. Solomon, R. W. Gunawardena, Y. Wang, and E. S. Knudsen Histone Deacetylation of RB-Responsive Promoters: Requisite for Specific Gene Repression but Dispensable for Cell Cycle Inhibition Mol. Cell. Biol., November 1, 2003; 23(21): 7719 - 7731. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lohr, C. Moritz, A. Contente, and M. Dobbelstein p21/CDKN1A Mediates Negative Regulation of Transcription by p53 J. Biol. Chem., August 29, 2003; 278(35): 32507 - 32516. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Fay, E. Large, M. Han, and M. Darland lin-35/Rb and ubc-18, an E2 ubiquitin-conjugating enzyme, function redundantly to control pharyngeal morphogenesis in C. elegans Development, July 15, 2003; 130(14): 3319 - 3330. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |